# A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA

> clinical trial · VERIFIED · 2026-06-30

Status: RECRUITING · Sponsor: Synusight Biotech (Shanghai) Co., Ltd. · Condition: Multiple System Atrophy (MSA)

- Company: Synusight Biotech (Shanghai) Co., Ltd.
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT07604116

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.